NO965563D0 - Behandling og profylakse av osteoporese - Google Patents

Behandling og profylakse av osteoporese

Info

Publication number
NO965563D0
NO965563D0 NO965563A NO965563A NO965563D0 NO 965563 D0 NO965563 D0 NO 965563D0 NO 965563 A NO965563 A NO 965563A NO 965563 A NO965563 A NO 965563A NO 965563 D0 NO965563 D0 NO 965563D0
Authority
NO
Norway
Prior art keywords
osteoporosis
prophylaxis
treatment
Prior art date
Application number
NO965563A
Other languages
English (en)
Other versions
NO965563L (no
Inventor
Toshihiko Fujiwara
Masaaki Miyamoto
Hiroyoshi Horikoshi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO965563D0 publication Critical patent/NO965563D0/no
Publication of NO965563L publication Critical patent/NO965563L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO965563A 1995-12-26 1996-12-23 Behandling og profylakse av osteoporese NO965563L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33844095 1995-12-26

Publications (2)

Publication Number Publication Date
NO965563D0 true NO965563D0 (no) 1996-12-23
NO965563L NO965563L (no) 1997-06-27

Family

ID=18318184

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965563A NO965563L (no) 1995-12-26 1996-12-23 Behandling og profylakse av osteoporese

Country Status (12)

Country Link
US (1) US5804590A (no)
EP (1) EP0783888A1 (no)
AU (1) AU714926B2 (no)
CA (1) CA2193751A1 (no)
CZ (1) CZ283229B6 (no)
HU (1) HUP9603607A3 (no)
IL (1) IL119894A (no)
NO (1) NO965563L (no)
NZ (1) NZ314003A (no)
RU (1) RU2146521C1 (no)
TW (1) TW401297B (no)
ZA (1) ZA9610901B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008208A (en) * 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
BR9711098B1 (pt) 1996-07-01 2011-10-04 compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
WO1998017267A1 (en) * 1996-10-23 1998-04-30 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US6011036A (en) * 1997-04-15 2000-01-04 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them
US6011031A (en) * 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
EP0977753A1 (en) * 1997-12-02 2000-02-09 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
GB2335597A (en) * 1998-03-27 1999-09-29 Glaxo Group Ltd Stereoisomers of Troglitazone in the Treatment of Diabetes
AU6331199A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders
AU6330999A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
WO2000018746A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
CZ20011524A3 (cs) 1998-10-29 2002-01-16 Board Of Regents, The University Of Texas System Pouľití thiazolidindionových derivátů pro prevenci děloľních stahů u předčasného porodu nebo laktace
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US6846496B1 (en) * 1999-10-15 2005-01-25 Orion Corporation Treatment of osteoporosis
GB0003310D0 (en) * 2000-02-15 2000-04-05 Univ Sheffield Bone formation
DE102005048483A1 (de) * 2005-10-07 2007-06-14 Schulz, Jörg, Prof. Dr.med. Mittel zur Therapie und Prophylaxe des Diabetes mellitus

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051189A (ja) 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPS6054379A (ja) * 1983-09-05 1985-03-28 Takeda Chem Ind Ltd 新規４ｈ−１−ベンゾピラン−４−オン誘導体，その製法および用途
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
NO179246C (no) * 1991-11-20 1996-09-04 Sankyo Co Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
JP3502403B2 (ja) * 1991-12-16 2004-03-02 アベンティス ファーマ株式会社 骨吸収抑制剤
NO302471B1 (no) 1991-12-26 1998-03-09 Sankyo Co Tiazolidinforbindelser og farmasöytisk preparat
NO302519B1 (no) 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
JPH05213763A (ja) * 1992-02-10 1993-08-24 Sanwa Kagaku Kenkyusho Co Ltd 易吸収活性化カルシウム製剤
ES2139633T3 (es) 1992-08-31 2000-02-16 Sankyo Co Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica.
JPH072848A (ja) * 1993-04-23 1995-01-06 Sankyo Co Ltd モルホリンおよびチオモルホリン誘導体
US5407947A (en) * 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
JPH07258132A (ja) * 1994-03-18 1995-10-09 Sankyo Co Ltd 新規ヒドロキノン化合物
NO303782B1 (no) * 1994-03-23 1998-08-31 Sankyo Co Tiazolidin- og oksazolidinderivater og farmas°ytiske preparater inneholdende slike, samt deres anvendelse til fremstilling av medikamenter
NO305987B1 (no) 1994-04-11 1999-08-30 Sankyo Co Heterosykliske forbindelser med antidiabetisk aktivitet, deres anvendelse og farmasoeytisk preparat inneholdende disse
US5476865A (en) * 1994-07-06 1995-12-19 Eli Lilly And Company Methods of inhibiting bone loss
JPH0892249A (ja) * 1994-07-20 1996-04-09 Sankyo Co Ltd スルホンアミド誘導体
CZ261095A3 (en) 1994-10-07 1996-04-17 Sankyo Co Oxime derivatives, process of their preparation, pharmaceutical composition containing thereof and their use
JPH08157461A (ja) * 1994-12-07 1996-06-18 Sankyo Co Ltd スルホン誘導体
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
HU9603607D0 (en) 1997-02-28
IL119894A (en) 2000-09-28
IL119894A0 (en) 1997-03-18
AU714926B2 (en) 2000-01-13
NO965563L (no) 1997-06-27
EP0783888A1 (en) 1997-07-16
RU2146521C1 (ru) 2000-03-20
HUP9603607A3 (en) 1999-03-29
US5804590A (en) 1998-09-08
AU7650396A (en) 1997-07-03
ZA9610901B (en) 1997-06-27
TW401297B (en) 2000-08-11
HUP9603607A2 (hu) 1998-07-28
CA2193751A1 (en) 1997-06-27
CZ382796A3 (en) 1997-07-16
CZ283229B6 (cs) 1998-02-18
NZ314003A (en) 2000-12-22

Similar Documents

Publication Publication Date Title
NO965563D0 (no) Behandling og profylakse av osteoporese
NO982311D0 (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt
FI964874A (fi) Vihannesten käsittely
NO974365D0 (no) Fremgangsmåte og krystallformer av 2-metyl-thieno-benzodiazepin
ZA965088B (en) Methods of preventing or treating allergles
NO962179L (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
HU9303218D0 (en) Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia
NO971900D0 (no) Blandinger og behandling av multippel sklerose
NO172838C (no) Fremgangsmaate og anlegg for behandling av avfallsprodukter
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO972426D0 (no) Metode for anvendelse av triarylethylenderivater ved behandling og forhindring av osteoporose
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
NO952568D0 (no) Behandling av cellulosemateriale og blandinger for anvendelse for dette
GB9502136D0 (en) Treatment of waste
EP0800396A4 (en) TREATMENT OF HYPERANDROGEN STATES
GB9711848D0 (en) Treatment and prophylaxis of infraction
NO921720L (no) Behandling av brystkjertelbetennelse
NO990283D0 (no) Formulering for behandling og/eller profylakse av demens
GB9317943D0 (en) Treatment of laminitis
GB9507825D0 (en) Method of treatment
ZA961785B (en) Treatment of eczema
GB9516572D0 (en) Prevention and/or treatment of disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application